From the *The Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia; and †Sydney Sexual Health Centre, Sydney Hospital, Sydney NSW 2000, Australia.
Conflicts of interest: B.D. and R.J.G. receive research funding from CSL Biotherapies. B.D. has received speaker’s honoraria from Merck and Sanofi-PasteurMSD.
Correspondence: Basil Donovan, MD, The Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia. E-mail: email@example.com.
Received for publication November 5, 2012, and accepted December 12, 2012.